Rare diseases
Investigational molecules
Locations
Back to Spain57 clinical trials in Gijon, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SpainA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
SpainA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
SpainA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SpainA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
SpainA study testing duvakitug for patients with moderately to severely active ulcerative colitis
SpainA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
SpainCemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
SpainA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
SpainA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on multiple myeloma and various lymphomas, including innovative combination therapies and novel treatment approaches for previously untreated and relapsed/refractory cases.
Studies evaluating breakthrough treatments like acalabrutinib, belantamab mafodotin, and linvoseltamab.
Clinical investigations targeting various digestive system conditions, with particular emphasis on pancreatic diseases and inflammatory bowel conditions.
Research includes both therapeutic interventions and surgical approaches for optimal patient outcomes.
Innovative studies examining treatments for coronary artery conditions and vascular events, with focus on both preventive measures and therapeutic interventions.
Investigations into beta-blockers, antiplatelet agents, and colchicine for various cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
